20356 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
COMPOUNDS, COMPOSITIONS, AND METHODS
#2N-methyl-D-aspartic Acid Receptor Modulators
#3PHENYL OXY AMIDE KINASE INHIBITORS
#4Tyrosine Kinase Inhibitors and Uses Thereof
#5VISCOUS COMPOSITION FOR TREATING ISCHEMIA
#6PAPD5 INHIBITORS AND METHODS OF USE THEREOF
#7COMPOUNDS FOR TARGETED PROTEIN DEGRADATION
#8SULFONYL DERIVATIVES AS CCR6 INHIBITORS
#9MODULATING THE ACUTE FOREIGN BODY REACTION TO REDUCE STENOSIS
#10METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#11COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH CALCITONIN RECEPTOR AND/OR AMYLIN RECEPTOR ACTIVITY
#12BICYCLIC PYRIDINE DERIVATIVE
#13USE OF MILVEXIAN FOR TREATING OR PREVENTING ISCHEMIC STROKE
#14CBL-B INHIBITORS AND METHODS OF USE THEREOF
#15N-(3-(BENZO[B]THIOPHENE-2-CARBOXAMIDO)-PHENYL)-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS LACTATE/ATP PRODUCTION INHIBITORS FOR THE TREATMENT OF CANCER
#16SUBSTITUTED 3,4-DIHYDROISOQUINOLIN-1(2H)-ONE DERIVATIVES AND RELATED USES
#17METHOD FOR DETECTING OR TREATING TRIPLE NEGATIVE BREAST CANCER
#18INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING NERVE CELL DEATH
#19PHARMACEUTICAL COMPOSITION FOR TREATING AND RESISTING BLOOD COAGULATION AND USE THEREOF
#20HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN
#21ARYL-ANILINE AND HETEROARYL-ANILINE COMPOUNDS FOR TREATMENT OF SKIN CANCERS
#22METHODS AND COMPOSITIONS FOR PREVENTING SKIN TOXICITIES CAUSED BY BIOLOGICAL TARGETED CANCER DRUGS
#23HETEROCYCLIC COMPOUND AS TAAR1 LIGAND AGONIST
#24COMPOUNDS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3
#25TREATMENT OR PREVENTION OF CARDIOVASCULAR EVENTS VIA THE ADMINISTRATION OF A COLCHICINE DERIVATIVE
#26CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES
#27METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#28Dispenseable formulation for active pharmaceutical ingredients
#29COMPOSITIONS AND METHODS FOR ASSAYING PLATELET REACTIVITY AND TREATMENT SELECTION
#30COMPOSITIONS AND METHODS FOR TREATING RENAL INJURY
#31PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS AS c-KIT KINASE INHIBITORS
#32THERAPY FOR ALCOHOL-RELATED LIVER DISEASE
#33TREATMENT OR PREVENTION OF CARDIOVASCULAR EVENTS VIA THE ADMINISTRATION OF A COLCHICINE DERIVATIVE
#34COMPOSITION OF MALUS NIEDZWETZKYANA DIECK AND PRUNUS CERASIFERA EHRHART AND USE THEREOF IN TERMS OF RESISTING ATHEROSCLEROSIS
#35INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR TREATING FIBROSIS
#36PROTEIN STABILIZING COMPOUNDS CONTAINING USP28 AND/OR USP25 TARGETING LIGANDS
#37USE OF CLOPIDOGREL OR COMBINATIONS THEREOF TO TREAT AMYOTROPHIC LATERAL SCLEROSIS, DAMAGES CAUSED BY THE NORMAL AGING PROCESS, NERVE INJURIES, MUSCULAR DYSTROPHY, STRENUOUS PHYSICAL ACTIVITIES AND OTHER CONDITIONS THAT AFFECT SYNAPSES AS WELL AS SKELETAL MUSCLES
#38COMPOUNDS AS CASEIN KINASE INHIBITORS
#39IMIDAZOLE DERIVATIVES AS ALK5 INHIBITORS
#40ESTROGEN-RELATED RECEPTOR ALPHA MODULATORS
#41COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH CALCITONIN RECEPTOR AND/OR AMYLIN RECEPTOR ACTIVITY
#42PHARMACEUTICAL COMPOSITION COMPRISING ANTIPLATELET AGENT AND GASTRIC ACID SECRETION INHIBITOR
#43NOVEL CARBAMATE COMPOUND AND USE THEREOF
#44COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY
#45VALPROIC ACID FOR THE TREATMENT OR PREVENTION OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH EXCESS FIBRIN DEPOSITION AND/OR THROMBUS FORMATION
#46COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS
#47COMBINATION OF A GREMLIN-1 ANTAGONIST WITH AN INHIBITOR OF RAS-RAF-MEK-ERK SIGNALLING
#48NEW USE
#49NEW USE
#50METHODS FOR ADMINISTERING FREEZE-DRIED PLATELET DERIVATIVE COMPOSITIONS TO SUBJECTS TREATED WITH A FACTOR XI INHIBITOR
#51COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE, MYODEGENERATIVE, AND LYSOSOMAL STORAGE DISORDERS
#52METHODS OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASES
#53cGAS INHIBITORS AND USES THEREOF
#54COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY
#55NOVEL BICYCLIC COMPOUNDS AS RAD51 INHIBITORS
#56AMIDE COMPOUND AS POTASSIUM CHANNEL REGULATOR, AND PREPARATION THEREFOR AND USE THEREOF
#57INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR MODULATING HEMATOPOIETIC STEM CELLS AND HEMATOPOIESIS
#58cGAS ANTAGONIST COMPOUNDS
#59SREBP-1 INHIBITOR AND PHARMACEUTICAL COMPOSITION FOR TREATING HYPERTRIGLYCERIDEMIA
#60TREATMENT OR PREVENTION OF CARDIOVASCULAR EVENTS VIA THE ADMINISTRATION OF A COLCHICINE DERIVATIVE
#61METHODS FOR SELECTING A CANCER PATIENT FOR TREATMENT
#62DNA POLYMERASE THETA INHIBITOR AND USE THEREOF
#63COMBINATION OF MUSCARINIC RECEPTOR POSITIVE MODULATORS AND NMDA POSITIVE ALLOSTERIC MODULATORS
#64CRYSTAL FORM OF FUSED RING DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#65COMPOUNDS, COMPOSITIONS, AND METHODS
#66METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#67FUSED BICYCLIC SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF
#68C-KIT INHIBITORS AND USES FOR TREATING AND PREVENTING INFLAMMATORY CONDITIONS
#69METHODS AND COMPOSITIONS FOR IMPROVING NEUROMUSCULAR JUNCTION MORPHOLOGY AND FUNCTION
#70INSTANT RELEASE PHARMACEUTICAL PREPARATION OF ANTICOAGULANT AND PREPARATION METHOD THEREFOR
#71SUBSTITUTED AZETIDINE DIHYDROTHIENOPYRIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
#72COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C-1 INHIBITOR
#73METHODS FOR TREATING NEUROGENERATIVE DISEASES
#74METHODS FOR TREATING AORTIC VALVE STENOSIS WITH A HEDGEHOG PATHWAY INHIBITOR
#75COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING LUNG INJURY
#76Aminopyridine-based MTA-Cooperative PRMT5 Inhibitors
#77Novel Dialkoxynaphtho[2,3-C]Furan-1(3H)-One Derivatives and Pharmaceutical Composition For Preventing or Treating Respiratory Disease or SARS-COV-2 Infection Disease, Comprising Same
#78NITRILE SUMO INHIBITORS AND USES THEREOF
#79METHODS FOR SELECTING AN INTRACRANIAL ATHEROSCLEROTIC DISEASE PATIENT FOR TREATMENT
#80Inhibitors of human immunodeficiency virus replication, method of making and method of using thereof
#81MULTI-TARGET INHIBITOR TARGETING HDAC AND NAD SYNTHESIS AND USE OF MULTI-TARGET INHIBITOR
#82Pharmaceutical Compound
#83METHODS OF PREVENTING SYMPTOMATIC ISCHEMIC STROKE
#84NOVEL COMPOUNDS WHICH BIND TO CEREBLON, AND METHODS OF USE THEREOF
#85COMPOUNDS AS MODULATORS OF ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1 (ERAP1)
#86THIOPHENE-BASED LIPIDS
#87COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF CORONAVIRUS AND RELATED DISORDERS
#88METHODS FOR INHIBITING MUSCLE ATROPHY
#89COMPOUNDS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE, DEGENERATIVE AND METABOLIC DISORDERS
#90COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS
#91BICYCLIC PYRIDINE DERIVATIVE
#92SUBSTITUTED TRICYCLIC AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME
#93PROTEASE INHIBITORS AND METHODS OF MAKING SAME
#94GluN2 Subunit Selective Antagonists of the N-Methyl-D-Aspartate Receptors
#95In Vitro Drugs from Prodrugs and Use Thereof
#96CYCLIC COMPOUNDS AND METHODS OF USING SAME
#97COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY
#98HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS
#99TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS
#100Anti-Androgens For The Treatment Of Non-Metastatic Castration-Resistant Prostate Cancer
#101INHIBITION OF PROSTAGLANDIN DEGRADING ENZYME 15-PGDH TO IMPROVE JOINT STRUCTURE AND FUNCTION
#102INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING NERVE CELL DEATH
#103METALLOENZYME MODULATORS
#104Treatment or prevention of cardiovascular events via the administration of a colchicine derivative
#105COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY
#106cGAS antagonist compounds
#107COMPOSITIONS AND METHODS FOR TREATING RENAL INJURY
#108METHOD FOR TREATING ACUTE ISCHEMIC STROKE
#109CLOPIDOGREL FOR USE IN THE TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
#110ELEVATION OF MITOCHONDRIAL BIOGENESIS AND FUNCTION BY INHIBITION OF PROSTAGLANDIN DEGRADING ENZYME 15-PGDH
#111Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent and statin
#112DEUTERATED RUC-4
#113COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH EXCESS FIBRIN DEPOSITION AND/OR THROMBUS FORMATION
#114BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF
#115Compositions and methods for assaying platelet reactivity and treatment selection
#116COMBINATIONS OF 15-PGDH INHIBITORS WITH CORTICOSTEROIDS AND/OR TNF INHIBITORS AND USES THEREOF
#117N-methyl-D-aspartic Acid Receptor Modulators
#118APPARATUSES AND METHODS FOR USE IN ULTRASOUND OPTICAL IMAGING
#119NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT
#120AMPK Activators and Methods of Use Thereof
#121INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR TREATING NEURODEGENERATION
#122Compositions and Methods of Modulating Short-Chain Dehydrogenase Activity
#123DRY POWDER FORMULATIONS FOR INHALATION
#124Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptor
#125Treatment or prevention of cardiovascular events via the administration of a colchicine derivative
#126Treatment or prevention of cardiovascular events via the administration of a colchicine derivative
#127MODULATION OF FACTOR 11 EXPRESSION
#128Pharmaceutical Composition Comprising Compound Capable of Penetrating Blood-Brain Barrier as Effective Ingredient for Preventing or Treating Brain Cancer
#129METHOD FOR DETECTING OR TREATING TRIPLE NEGATIVE BREAST CANCER
#130LURBINECTEDIN IN THE TREATMENT OF MALIGNANT MESOTHELIOMA
#131RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA
#132Treatments of prostate cancer
#133THIENOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CORONAVIRUS INFECTION
#134Dry powder formulations for inhalation
#135Methods of Treating, Reducing the Incidence of, and/or Preventing Ischemic Events
#136REJUVENATION OF AGED TISSUES BY INHIBITION OF THE PGE2 DEGRADING ENZYME, 15-PGDH
#137Pharmaceutical Composition Comprising Compound Capable of Penetrating Blood-Brain Barrier as Effective Ingredient for Preventing or Treating Brain Cancer
#138BIOMARKER-BASED THERAPEUTIC COMPOSITION
#139INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR TREATING CORONARY DISORDERS
#140USE OF BROMODOMAIN INHIBITORS FOR TREATMENT OF HUNTINGTON'S DISEASE
#141USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF DIABETIC NEPHROPATHY
#142Compounds that Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic Disease
#143COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY
#144Anat Inhibitors and Methods of Use Thereof
#145Instant release pharmaceutical preparation of anticoagulant and preparation method therefor
#146Inhibition of BRD Proteins Suppresses the Phenotype of Uterine Fibroids
#147Use of a thienopyridone derivative in the treatment of autosomal dominant polycystic kidney disease (ADPKD)
#148INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR MODULATING HEMATOPOIETIC STEM CELLS AND HEMATOPOIESIS
#149RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF TUBERCULOSIS
#150COMBINATION ANTI-CANCER THERAPIES WITH INDUCERS OF IRON-DEPENDENT CELLULAR DISASSEMBLY
#151Use of a thienopyridone derivative in the treatment of adrenoleukodystrophy or adrenomyeloneuropathy
#152SUBSTITUTED BICYCLIC AND TRICYCLIC UREAS AND AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME
#153N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitors
#154MEDICAL USE OF ICARITIN
#155MULTI-TARGET TYROSINE KINASE INHIBITOR
#156PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER IN WHICH KRAS MUTATION AND ACTIVATED RON ARE PRESENT
#157PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
#158Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
#159METHOD OF TREATING PANCREATIC CANCER
#160ORAL PHARMACEUTICAL SOLUTION OF CLOPIDOGREL
#161NON-AQUEOUS SUSTAINED RELEASE DRUG DELIVERY SYSTEM
#162COMPOSITIONS AND METHODS FOR TREATING RENAL INJURY
#163COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
#164Carboxylic acid aromatic amides
#165COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY
#166CHEMOTHERAPEUTIC DRUG IMPLANT
#167EPAC1 INHIBITORS FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
#168Anti-Androgens For The Treatment Of Non-Metastatic Castration-Resistant Prostate Cancer
#169ARYL-ANILINE AND HETEROARYL-ANILINE COMPOUNDS FOR TREATMENT OF BIRTHMARKS
#170Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation
#171COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS
#172SMALL MOLECULE ACTIVATORS OF INTERFERON REGULATORY FACTOR 3 AND METHODS OF USE THEREOF
#173ESTROGEN-RELATED RECEPTOR ALPHA MODULATORS
#174ANTIVIRAL COMPOUNDS
#175TREATMENT OF MAJOR DEPRESSIVE DISORDER BY LOW DOSE INTERLEUKIN-2
#176CGAS antagonist compounds
#177ALDEHYDE CONJUGATES AND USES THEREOF
#178Methods for treating pulmonary fibrosis with a hedgehog pathway inhibitor
#179COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE
#180OXATHIAZIN_DIOXIDE FOR TREATING, PREVENTING, INHIBITING OR REDUCING CYTOKINE RELEASE
#181METHODS OF REJUVENATING AGED TISSUE BY INHIBITING 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE (15-PGDH)
#182AMINO ACID TRANSPORT INHIBITORS AND THE USES THEREOF
#183METHODS FOR INHIBITING MUSCLE ATROPHY
#184TREATMENT OF KIDNEY DISEASES ASSOCIATED WITH ELEVATED AVP
#185PHARMACEUTICAL COMBINATION AND METHOD FOR OVERCOMING IMMUNE SUPPRESSION OR STIMULATING IMMUNE RESPONSE AGAINST CANCER
#186COMBINATION CONTAINING SGC ACTIVATORS AND MINERALOCORTICOID RECEPTOR ANTAGONISTS
#187Dihydrothieno[3,2-b]pyridine compounds
#188Treatments of prostate cancer
#189Compounds and methods for treating cancer
#190AMPK/CASPASE-6 AXIS CONTROLS LIVER DAMAGE IN NONALCOHOLIC STEATOHEPATITIS
#191COLLAGEN P4H1 INHIBITOR AND ITS USE
#192Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
#193Pan-RAF kinase inhibitor and use thereof
#194Synergistically cooperative compositions useful for soft tissue augmentation, drug delivery and related fields
#195ARYL-ANILINE AND HETEROARYL-ANILINE COMPOUNDS FOR TREATMENT OF SKIN CANCERS
#196METHODS AND FORMULATIONS TO TREAT MITOCHONDRIAL DYSFUNCTION
#197PEPTIDE DIRECTED PROTEIN KNOCKDOWN
#198PREVENTION OF ATHEROSCLEROTIC EVENTS WITH DIRECT FACTOR Xa INHIBITORS
#199Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer
#200Methods of treating aneurysms
#2012,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors
#202Method of Treatment and Pharmaceutical Composition for Morning Hypertension
#203HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS
#204DRY POWDER FORMULATIONS FOR INHALATION
#205COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING DEPRESSION
#206Methods for diagnosing and/or treating acute or chronic liver, kidney or lung disease
#207DRY POWDER COMPOSITIONS WITH MAGNESIUM STEARATE
#208Inhibitors of SARM1 in combination with neuro-protective agents
#209S3QELS TO PROTECT AGAINST INTESTINAL PERMEABILITY
#210RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA
#211Combination of low dose IL-2 and an inhibitor of Treg IL-2R desensitization to treat autoimmune and allergic inflammatory diseases
#212TOPOISOMERASE II CATALYTIC INHIBITOR COMPOUND THERAPEUTICS FOR CANCER TREATMENT, METHODS AND USES
#213Compositions and methods for treating neurodegenerative, myodegenerative, and lysosomal storage disorders
#214Deuterated RUC-4
#215N-methyl-D-aspartic acid receptor modulators
#216METHODS FOR TREATING AORTIC VALVE STENOSIS WITH A HEDGEHOG PATHWAY INHIBITOR
#217INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR TREATING FIBROSIS
#218Pharmaceutical Composition Comprising Compound Capable of Penetrating Blood-Brain Barrier as Effective Ingredient for Preventing or Treating Brain Cancer
#219Pharmaceutical composition comprising antiplatelet agent and gastric acid secretion inhibitor
#220Compounds and compositions for the inhibition of NAMPT
#221Treatments of prostate cancer
#222ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE
#223Methods and compositions for treating autophagy related disease states and conditions utilizing AMPK activation
#224Treating and preventing disease with TMA and TMAO lowering agents
#225Dry powder formulations for inhalation
#226THIENOPIPERIDINE DERIVATIVE AND USE THEREOF
#227PAPD5 inhibitors and methods of use thereof
#228Modulation of factor 11 expression
#229Pyrrolidine and piperidine compounds
#230Selective HDAC6 inhibitors
#231N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitors
#232COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY
#233COMPOSITIONS AND METHODS FOR TREATING RENAL INJURY
#234Inhibitors of short-chain dehydrogenase activity for promoting neurogenesis and inhibiting nerve cell death
#235COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY
#236Anti-Androgens For The Treatment Of Non-Metastatic Castration-Resistant Prostate Cancer
#237Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
#238Treatment or prevention of cardiovascular events via the administration of a colchicine derivative
#239VISCOUS COMPOSITION FOR TREATING ISCHEMIA
#240Treatment or prevention of cardiovascular events via the administration of a colchicine derivative
#241Treatment or prevention of cardiovascular events via the administration of a colchicine derivative
#242Treatment or prevention of cardiovascular events via the administration of a colchicine derivative
#243Use of I-BRD9 or derivatives thereof in preparing anti-epileptic drugs
#244PARTICLES, COMPOSITIONS AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS
#245COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY
#246Maintenance of platelet inhibition during antiplatelet therapy
#247Methods for treating cognitive deficits in a subject having schizophrenia, bipolar disorder, or psychiatric depression, and exhibiting cognitive deficits by administering an antagonist of the Na+-K+-2Cl-cation-chloride cotransporter isoform 1 (NKCC1)
#248Instant release pharmaceutical preparation of anticoagulant and preparation method therefor
#249Drone based security system
#250Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer
#251Unit aerosol doses for anticoagulation
#252Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer
#253RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF TUBERCULOSIS
#254COMPOUNDS AND METHODS FOR TREATING OR PREVENTING FIBROSIS
#255STRUCTURAL BASIS FOR OUTER MEMBRANE USHER ACTIVATION TO CATALYZE P PILUS ASSEMBLY
#256HETEROCYCLICS AS INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR
#257ALDEHYDE CONJUGATES AND USES THEREOF
#258Treatment of kidney diseases associated with elevated AVP
#259Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
#260Treating and preventing disease with TMA and TMAO lowering agents
#261THERAPEUTIC AND PROPHYLACTIC METHODS, USES AND COMPOSITIONS COMPRISING ANNEXIN A5
#262Compounds that enhance Atoh1 expression
#263Compositions and methods for assaying platelet reactivity and treatment selection
#264INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR MODULATING HEMATOPOIETIC STEM CELLS AND HEMATOPOIESIS
#265COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY
#266LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS
#267METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE
#268COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C-1 INHIBITOR
#269Use of bromodomain-containing protein 9 antagonists in combination with vitamin D receptor agonists in diabetes treatment
#270COMPLEX FORMULATION COMPRISING HMG-COA REDUCTASE INHIBITOR AND CLOPIDOGREL
#271Dry powder formulations for inhalation
#272N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitors
#273Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
#274Methods for inhibiting muscle atrophy
#275Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof
#276COMPOUNDS, COMPOSITIONS AND METHODS USEFUL FOR CHOLESTEROL MOBILIZATION
#277Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
#278Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
#279COMBINATION THERAPIES
#280Inhibitors of short-chain dehydrogenase activity for treating coronary disorders
#281Pharmaceutical Compositions For Poorly Water-Soluble Compounds
#282Heteroaryl estrogen receptor modulators and uses thereof
#283Modulation of Factor 11 expression
#284Methods for treating aortic valve stenosis with a hedgehog pathway inhibitor
#285Agent for removing undifferentiated iPS cells
#286Compounds and compositions for the inhibition of NAMPT
#287Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent
#288Compositions and methods of modulating short-chain dehydrogenase activity
#289Negative allosteric modulators of MGLUR5 for use in the treatment of mature brain damages
#290THERAPEUTIC AGENT FOR MOTOR DISORDERS
#291Dry powder compositions with magnesium stearate
#292Methods of treating, reducing the incidence of, and/or preventing ischemic events
#293Maintenance of platelet inhibition during antiplatelet therapy
#294Inhaled aspirin and magnesium to treat inflammation
#295Peptide directed protein knockdown
#296Treatment or prevention of cardiovascular events via the administration of a colchicine derivative
#297Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors
#298Methods for treating testosterone deficiency in men and methods for precise dosing of UGT2B17 substrate drugs
#299One-stop Surgical Method of Coronary Intervention Therapy Combined with Endovascular Aortic Repair
#300COMPOUNDS AND METHODS FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE